OTC Product Roundup: Skin Care

News
Slideshow
Drug Topics JournalDrug Topics May 2024
Volume 168
Issue 04

Spring and summer not only bring sunshine, but also stronger UV rays. Whether you are barbecuing, swimming, or taking a hike, skin protection is paramount while soaking up the sunshine.

READ MORE: Dermatology Resource Center

Download Issue PDF
Articles in this issue
FDA Approves Novel Topical Therapy for Molluscum Contagiosum
FDA Approves Novel Topical Therapy for Molluscum Contagiosum
Post–COVID-19 Condition: The Frustrating Fight for Recognition and Treatment
Post–COVID-19 Condition: The Frustrating Fight for Recognition and Treatment
The Flawless Fallacy: A Pharmacist’s Guide to Skin Care in the Digital Age
The Flawless Fallacy: A Pharmacist’s Guide to Skin Care in the Digital Age
Reviewing Efficacy, Safety of Weight Loss Therapies in T1D
Reviewing Efficacy, Safety of Weight Loss Therapies in T1D
Sunscreen Safety: What Every Pharmacist Needs to Know
Sunscreen Safety: What Every Pharmacist Needs to Know
In Frankfurt, Pharmacy Takes a Different Approach
In Frankfurt, Pharmacy Takes a Different Approach
OTC Product Roundup: Skin Care
OTC Product Roundup: Skin Care
How Individuals are Committing E-Prescription Fraud
How Individuals are Committing E-Prescription Fraud
Measles Cases in the US Increased Significantly in 2024
Measles Cases in the US Increased Significantly in 2024
Pfizer Announces Positive Top-Line Data for Abrysvo Immunization in Adults Aged 18 to 59 Years
Pfizer Announces Positive Top-Line Data for Abrysvo Immunization in Adults Aged 18 to 59 Years
Federal Retail Pharmacy Program Partners Critical in Ensuring Vaccine Access
Federal Retail Pharmacy Program Partners Critical in Ensuring Vaccine Access
Exploring the Role of Pharmacists as Facilitators of Harm Reduction Resources
Exploring the Role of Pharmacists as Facilitators of Harm Reduction Resources
Pharmacists Should Adapt Harm Reduction Efforts to Address Unregulated Substances
Pharmacists Should Adapt Harm Reduction Efforts to Address Unregulated Substances
Psychedelic Therapeutics: Education, Advocacy Key to Overcoming Integration Hurdles
Psychedelic Therapeutics: Education, Advocacy Key to Overcoming Integration Hurdles
Are Psychedelic Therapeutics a New Frontier of Mental Health Treatment?
Are Psychedelic Therapeutics a New Frontier of Mental Health Treatment?
Recent Videos
Related Content
FDA Accepts BLA Resubmission for Epidermolysis Bullosa Gene Therapy

FDA Accepts BLA Resubmission for Epidermolysis Bullosa Gene Therapy

Killian Meara
November 12th 2024
Article

The agency assigned prademagene zamikeracel a PDUFA target action date of April 29, 2025.

FDA Approves Journey Medical’s Emrosi for Rosacea

FDA Approves Journey Medical’s Emrosi for Rosacea

Lauren Massaro
November 5th 2024
Article

“Emrosi has potential to become the best-in-class oral medication to treat the condition,” said the CEO of Journey Medical.

Supplement Snapshot: Vitamin D and Respiratory Tract Infections

Supplement Snapshot: Vitamin D and Respiratory Tract Infections

Lauren Massaro
October 11th 2024
Article

Recent research on vitamin D supplementation and respiratory tract infections can help guide pharmacists in counseling patients.

FDA Approves Bimekizumab-Bkzx for Psoriatic Arthritis, 2 Other Indications

FDA Approves Bimekizumab-Bkzx for Psoriatic Arthritis, 2 Other Indications

Killian Meara
September 23rd 2024
Article

The monoclonal antibody was also approved for active non-radiographic axial spondyloarthritis and active ankylosing spondylitis.

First FDA Cleared Nonprescription ED Treatment Available for Preorder

First FDA Cleared Nonprescription ED Treatment Available for Preorder

Lauren Biscaldi, MS, Managing Editor
September 23rd 2024
Article

Eroxon topical gel addresses a significant unmet need for men experiencing erectile dysfunction.

FDA Accepts NDA for Delgocitinib Cream to Treat Chronic Hand Eczema

FDA Accepts NDA for Delgocitinib Cream to Treat Chronic Hand Eczema

Killian Meara
September 23rd 2024
Article

LEO Pharma expects the regulatory review process to be completed in the second half of 2025.

© 2024 MJH Life Sciences

All rights reserved.